Healthcare innovation

CinCor Pharma shares surge 144% on AstraZeneca…

CinCor Pharma shares surge 144% on AstraZeneca…


The acquisition is priced at a 206% premium compared to CinCor’s market price last week.

Source

Leave your thought here

Your email address will not be published. Required fields are marked *